Gates Research Institute to Develop Glaxo’s Promising TB Vaccine

Bookmark
(Bloomberg) -- GlaxoSmithKline Plc licensed a promising vaccine against tuberculosis to the Bill & Melinda Gates Medical Research Institute in a move the drugmaker said will help bring prevention o...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.